Skip to main
RETA
RETA logo

Reata Pharmaceuticals (RETA) Stock Forecast & Price Target

Reata Pharmaceuticals (RETA) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 21%
Buy 36%
Hold 43%
Sell 0%
Strong Sell 0%
Reata Pharmaceuticals (RETA) has been analyzed by 14 analysts, with a consensus rating of Buy. 21% of analysts recommend a Strong Buy, 36% recommend Buy, 43% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Reata Pharmaceuticals and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Reata Pharmaceuticals (RETA) Forecast

Analysts have given Reata Pharmaceuticals (RETA) a Buy based on their latest research and market trends.

According to 14 analysts, Reata Pharmaceuticals (RETA) has a Buy consensus rating as of Jul 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $144.57, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $144.57, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Reata Pharmaceuticals (RETA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.